We are live on ! Find out more
Name Net reduced
positions
Reduced positions Increased positions Return since
31 Mar ‘18
VNDA icon
1201
Vanda Pharmaceuticals
VNDA
$329M
5 45 40 67.7%
CVGI icon
1202
Commercial Vehicle Group
CVGI
$129M
5 40 35 59%
AMSF icon
1203
AMERISAFE
AMSF
$485M
5 61 56 52.7%
EFC
1204
Ellington Financial
EFC
$1.75B
5 15 10 8.37%
TVRD
1205
Tvardi Therapeutics
TVRD
$24M
5 35 30 99.6%
NVS icon
1206
Novartis
NVS
$294B
5 377 372 113%
RNAC icon
1207
Cartesian Therapeutics
RNAC
$302M
5 22 17 96.7%
TBI
1208
Trueblue
TBI
$325M
5 76 71 58.8%
ABEV icon
1209
Ambev
ABEV
$44.4B
5 117 112 60.4%
NVCR icon
1210
NovoCure
NVCR
$2.09B
5 46 41 17.5%
AKO.A icon
1211
Embotelladora Andina Series A
AKO.A
$3.75B
5 6 1 6.78%
PTCT icon
1212
PTC Therapeutics
PTCT
$5.99B
5 45 40 165%
ARR
1213
Armour Residential REIT
ARR
$2.32B
5 47 42 85.9%
SID icon
1214
Companhia Siderúrgica Nacional
SID
$1.41B
5 25 20 59.7%
BBAR icon
1215
BBVA Argentina
BBAR
$2.98B
4 22 18 36%
SMLV icon
1216
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$258M
4 18 14 79.7%
SENEA icon
1217
Seneca Foods Class A
SENEA
$1.3B
4 33 29 594%
RXL icon
1218
ProShares Ultra Health Care
RXL
$93.3M
4 8 4 185%
MLP icon
1219
Maui Land & Pineapple Co
MLP
$315M
4 20 16 36%
RBA icon
1220
RB Global
RBA
$15.9B
4 69 65 173%
CARZ icon
1221
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$47.9M
4 6 2 161%
QTWO icon
1222
Q2 Holdings
QTWO
$4.1B
4 56 52 44.2%
BTAL icon
1223
AGF US Market Neutral Anti-Beta Fund
BTAL
$298M
4 4 0 37.9%
RA
1224
Brookfield Real Assets Income Fund
RA
$698M
4 26 22 42%
WEYS icon
1225
Weyco Group
WEYS
$428M
4 24 20 33.5%